Wako, Japan

Akishi Onishi

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Riken Corporation, Sumitomo Pharma Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akishi Onishi. Retrieved from https://idiyas.com/inventor/akishi-onishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akishi Onishi: Innovator in Retinal Tissue Production

Introduction

Akishi Onishi is a notable inventor based in Wako, Japan. He has made significant contributions to the field of retinal tissue production, focusing on methods that enhance the understanding and treatment of retinal diseases.

Latest Patents

Onishi holds a patent for a method for producing retinal tissues. This invention aims to suppress the differentiation of ganglion cells, amacrine cells, horizontal cells, and/or bipolar cells in neural retina tissue containing photoreceptor precursors and/or photoreceptors. The method involves culturing retinal tissue that includes neural retinal progenitor cells at various differentiation stages, utilizing a medium that contains a thyroid gland hormone signal transduction pathway agonist.

Career Highlights

Throughout his career, Onishi has worked with prominent organizations such as Riken Corporation and Sumitomo Pharma Co., Ltd. His work has been instrumental in advancing the field of retinal research and therapy.

Collaborations

Onishi has collaborated with notable colleagues, including Daiki Nukaya and Mototsugu Eiraku. Their combined efforts have contributed to the development of innovative solutions in retinal tissue production.

Conclusion

Akishi Onishi's work in the field of retinal tissue production showcases his dedication to advancing medical science. His innovative methods and collaborations highlight the importance of research in improving treatments for retinal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…